'Integrative Physiology 2.0': Integration of systems biology into physiology and its application to cardiovascular homeostasis

Journal of Physiology

Volumn 589, Issue 5, 2011, Pages 1037-1045

  Kuster, Diederik W D ^a,b   Merkus, Daphne ^a   Van Der Velden, Jolanda ^c   Verhoeven, Adrie J M ^b   Duncker, Dirk J ^a  

^a Experimental Cardiology   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN 5; PHOSPHODIESTERASE III INHIBITOR; PHOSPHODIESTERASE IV; UNCLASSIFIED DRUG;

CARDIOVASCULAR SYSTEM; CATALYSIS; CORONARY VASCULAR RESISTANCE; GENE FUNCTION; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE BLOOD FLOW; HEART OUTPUT; HEART VENTRICLE REMODELING; HOLISTIC CARE; HOMEOSTASIS; HUMAN; HUMAN GENOME; INTEGRATIVE MEDICINE; MYOFILAMENT; NONHUMAN; PLASTICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SWINE; SYSTEMS BIOLOGY; TRANSCRIPTION REGULATION;

ANIMALS; CARDIOVASCULAR PHYSIOLOGICAL PHENOMENA; EXERCISE; GENOMICS; HOMEOSTASIS; HUMANS; PHYSIOLOGY; SYSTEMS BIOLOGY;

EID: 79951969176     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2010.201533     Document Type: Review

References (38)

1. Adams KF (2010). Systems biology and heart failure: concepts, methods, and potential research applications. Heart Fail Rev 15, 371-398.
2. Boontje NM, Merkus D, Zaremba R, Versteilen A, de Waard MC, Mearini G, de Beer VJ, Carrier L, Walker LA, Niessen HW, Dobrev D, Stienen GJ, Duncker DJ & van der Velden J (2010). Enhanced myofilament responsiveness upon beta-adrenergic stimulation in post-infarct remodeled myocardium. J Mol Cell Cardiol Dec 13, Epub ahead of print.
3. Boushel R (2003). Metabolic control of muscle blood flow during exercise in humans. Can J Appl Physiol 28, 754-773.
4. Brand T, Sharma HS, Fleischmann KE, Duncker DJ, McFalls EO, Verdouw PD & Schaper W (1992). Proto-oncogene expression in porcine myocardium subjected to ischemia and reperfusion. Circ Res 71, 1351-1360.
5. CIBIS Investigators and Committees (1994). A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation 90, 1765-1773.
6. CIBIS-II Investigators and Committees (1999). The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 353, 9-13.
7. Duncker DJ & Bache RJ (2008). Regulation of coronary blood flow during exercise. Physiol Rev 88, 1009-1086.
8. Duncker DJ, Boontje NM, Merkus D, Versteilen A, Krysiak J, Mearini G, El Armouche A, de Beer VJ, Lamers JM, Carrier L, Walker LA, Linke WA, Stienen GJ & van der Velden J (2009). Prevention of myofilament dysfunction by β-blocker therapy in postinfarct remodeling. Circ Heart Fail 2, 233-242.
9. Duncker DJ, de Beer VJ & Merkus D (2008). Alterations in vasomotor control of coronary resistance vessels in remodelled myocardium of swine with a recent myocardial infarction. Med Biol Eng Comput 46, 485-497.
10. 2+ sensitizer EMD 57033 in exercising pigs with infarction-induced chronic left ventricular dysfunction. Br J Pharmacol 134, 553-562.
11. Duncker DJ, Haitsma DB, Liem DA, Verdouw PD & Merkus D (2005). Exercise unmasks autonomic dysfunction in swine with a recent myocardial infarction. Cardiovasc Res 65, 889-896.
12. Duncker DJ & Merkus D (2007). Exercise hyperaemia in the heart: the search for the dilator mechanism. J Physiol 583, 847-854.
13. Frey N & Olson EN (2003). Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol 65, 45-79.
14. Guyton AC (1992). Kidneys and fluids in pressure regulation. Small volume but large pressure changes. Hypertension 19, I2-I8.
15. Haitsma DB, Bac D, Raja N, Boomsma F, Verdouw PD & Duncker DJ (2001). Minimal impairment of myocardial blood flow responses to exercise in the remodeled left ventricle early after myocardial infarction, despite significant hemodynamic and neurohumoral alterations. Cardiovasc Res 52, 417-428.
16. Heineke J & Molkentin JD (2006). Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 7, 589-600.
17. Hester RL, Iliescu R, Summers R and Coleman TG (2011). Systems biology and integrative physiological modelling. J Physiol 589, 1053-1060.
18. Katz AW (1988). Molecular biology in cardiology, a paradigmatic shift. J Mol Cell Cardiol 20, 355-366.
19. Katz AW (2003). The "modern" view of heart failure: how did we get here? Circ Heart Failure 1, 63-71.
20. Kuster DW, Merkus D, Verhoeven AJ & Duncker DJ (2010). Integrative approach to study the molecular basis of post-myocardial infarction remodeling in porcine heart. FASEB J 24, 110.8.
21. Laughlin MH, McAllister RM, Jasperse JL, Crader SE, Williams DA & Huxley VH (1996). Endothelium-medicated control of the coronary circulation. Exercise training-induced vascular adaptations. Sports Med 22, 228-250.
22. Levy D, Garrison RJ, Savage DD, Kannel WB & Castelli WP (1990). Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322, 1561-1566.
23. MERIT-HF Study Group (1999). Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 353, 2001-2007.
24. Merkus D, Haitsma DB, Sorop O, Boomsma F, de Beer VJ, Lamers JM, Verdouw PD & Duncker DJ (2006). Coronary vasoconstrictor influence of angiotensin II is reduced in remodeled myocardium after myocardial infarction. Am J Physiol Heart Circ Physiol 291, H2082-H2089.
25. Merkus D, Houweling B, van den Meiracker AH, Boomsma F & Duncker DJ (2005a). Contribution of endothelin to coronary vasomotor tone is abolished after myocardial infarction. Am J Physiol Heart Circ Physiol 288, H871-H880.
26. ATP channels to coronary vasomotor tone regulation is enhanced in exercising swine with a recent myocardial infarction. Am J Physiol Heart Circ Physiol 288, H1306-H1313.
27. Mudd JO & Kass DA (2008). Tackling heart failure in the twenty-first century. Nature 451, 919-928.
28. Murrant CL & Sarelius IH (2002). Multiple dilator pathways in skeletal muscle contraction-induced arteriolar dilations. Am J Physiol Regul Integr Comp Physiol 282, R969-R978.
29. Narula J, Haider N, Arbustini E & Chandrashekhar Y (2006). Mechanisms of disease: apoptosis in heart failure-seeing hope in death. Nat Clin Pract Cardiovasc Med 3, 681-688.
30. Packer M, Carver JR, Rodeheffer RJ, Ivanhoe RJ, DiBianco R, Zeldis SM, Hendrix GH, Bommer WJ, Elkayam U, Kukin ML, et al (1991). Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med 325, 1468-1475.
31. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ Jr, Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker GC, et al (1992). Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 327, 669-677.
32. Rowell LB (2004). Ideas about control of skeletal and cardiac muscle blood flow (1876-2003): cycles of revision and new vision. J Appl Physiol 97, 384-392.
33. Spinale FG (2007). Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function. Physiol Rev 87, 1285-1342.
34. Tune JD, Gorman MW & Feigl EO (2004). Matching coronary blood flow to myocardial oxygen consumption. J Appl Physiol 97, 404-415.
35. Vakili BA, Okin PM & Devereux RB (2001). Prognostic implications of left ventricular hypertrophy. Am Heart J 141, 334-341.
36. van der Velden J, Merkus D, Klarenbeek BR, James AT, Boontje NM, Dekkers DH, Stienen GJ, Lamers JM & Duncker DJ (2004). Alterations in myofilament function contribute to left ventricular dysfunction in pigs early after myocardial infarction. Circ Res 95, e85-e95.
37. van Kats JP, Duncker DJ, Haitsma DB, Schuijt MP, Niebuur R, Stubenitsky R, Boomsma F, Schalekamp MA, Verdouw PD & Danser AH (2000). Angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade prevent cardiac remodeling in pigs after myocardial infarction: role of tissue angiotensin II. Circulation 102, 1556-1563.
38. van Veldhuisen DJ, van den Heuvel AF, Blanksma PK & Crijns HJ (1998). Ischemia and left ventricular dysfunction: a reciprocal relation? J Cardiovasc Pharmacol 32(Suppl 1), S46-S51.